Preclinical biotech developing small molecule therapies for genetically defined cancers.
Industry: Health Care
First Day Return: +9.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/26/2021 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 9.0 |
Deal Size ($mm) | $153 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/15/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $153 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Redwood City, CA, United States |
Founded | 2017 |
Employees at IPO | 12 |
Website www.biomeafusion.com |